Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients

    Joong-Woon Choi, Dong-Woo Suh, Bark‐Lynn Lew, Woo‐Young Sim
    Studysummary In this study, simvastatin/ezetimibe treatment led to partial hair regrowth in about 29% of patients with recalcitrant alopecia areata, suggesting it may be a viable alternative therapy for this condition.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on anndermatol.org →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Genome-Wide Association Study in Alopecia Areata Implicates Both Innate and Adaptive Immunity Nature · 2010
    2. Guidelines for the Management of Alopecia Areata British Journal of Dermatology · 2003
    3. Alopecia Areata: A Review of Treatments and Their Efficacy Archives of dermatology · 1992

    Related research 1

    1. Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients Annals of dermatology/Annals of Dermatology · 2017